Insider · CIK 0001578266
Jerome J. Lande
Files at ITRI (ITRON, INC.), CNMD (CONMED Corp). First filing Mar 7, 2024, latest Mar 7, 2024.
In brief
Jerome J. Lande files SEC Form 4 as director at ITRI (ITRON, INC.), and also at CNMD (CONMED Corp). Since Mar 7, 2024, Jerome J. Lande has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.4M, the latest filed on Mar 7, 2024.
A track record needs three past buys with six months of prices behind them; Jerome J. Lande has 0, so none is measured yet.
The newest scored trade: sold $1.4M of ITRI on Mar 7, 2024, filed Mar 7, 2024, scored 75 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ITRI: ITRON, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 75Notable | ITRON, INC. | $1.4M 14,896 shares | -72% | +88% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 7, 2024 | ITRI ITRON, INC. | 5,720 0.01% of outstanding | $546k | Mar 7, 2024 | none |
| Mar 7, 2024 | ITRI ITRON, INC. | 9,176 0.02% of outstanding | $873k | Mar 7, 2024 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ITRI ITRON, INC. | AGrant or award Common Stock | +608 | $0.00 | $0 | 11,373 | 9 d ago |
| Jul 1, 2026 | ITRI ITRON, INC. | AGrant or award Common Stock | +621 | $0.00 | $0 | 10,765 | Jul 2, 2026 |
| Apr 1, 2026 | ITRI ITRON, INC. | AGrant or award Common Stock | +580 | $0.00 | $0 | 10,144 | Apr 2, 2026 |
| Jan 2, 2026 | ITRI ITRON, INC. | AGrant or award Common Stock | +555 | $0.00 | $0 | 9,564 | Jan 9, 2026 |
| Jan 2, 2026 | ITRI ITRON, INC. | AGrant or award Common Stock | +529 | $0.00 | $0 | 9,538 | Jan 5, 2026 |
| Oct 1, 2025 | ITRI ITRON, INC. | AGrant or award Common Stock | +408 | $0.00 | $0 | 9,009 | Oct 2, 2025 |
| Jul 1, 2025 | ITRI ITRON, INC. | AGrant or award Common Stock | +377 | $0.00 | $0 | 8,601 | Jul 2, 2025 |
| Apr 1, 2025 | ITRI ITRON, INC. | AGrant or award Common Stock | +472 | $0.00 | $0 | 8,224 | Apr 1, 2025 |
| Jan 2, 2025 | ITRI ITRON, INC. | AGrant or award Common Stock | +460 | $0.00 | $0 | 7,752 | Jan 3, 2025 |
| May 31, 2024 | CNMD CONMED Corp | MOption exercise Common Stock | +302 | $0.00 | $0 | 3,856 | Jun 4, 2024 |
| May 31, 2024 | CNMD CONMED Corp | MOption exercise Rsus (restricted Stock Units)derivative | -302 | $0.00 | $0 | 0 | Jun 4, 2024 |
| Mar 7, 2024 | ITRI ITRON, INC. | SOpen-market sale Common Stock | -5,720 | $95.50 | $546k | 14,926 | Mar 7, 2024 |
| Mar 7, 2024 | ITRI ITRON, INC. | SOpen-market sale Common Stock | -3,169 | $94.68 | $300k | 11,757 | Mar 7, 2024 |
| Mar 7, 2024 | ITRI ITRON, INC. | SOpen-market sale Common Stock | -6,007 | $95.32 | $573k | 5,750 | Mar 7, 2024 |
| Jan 2, 2024 | ITRI ITRON, INC. | AGrant or award Common Stock | +665 | $0.00 | $0 | 20,646 | Jan 4, 2024 |
Questions about Jerome J. Lande
Answered from the filings on this page, as of the latest one.
Is Jerome J. Lande buying or selling?
Not in the last 12 months. Jerome J. Lande's latest open-market trade on SEC Form 4 was sold $1.4M of ITRI on Mar 7, 2024.
How did Jerome J. Lande's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jerome J. Lande has 0.
Where does Jerome J. Lande file Form 4?
Jerome J. Lande has filed Form 4 at ITRI (ITRON, INC.); CNMD (CONMED Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.